EUVIMEDEUVIMED entdecken
Querschnittstudie

Correlation analysis of 25(OH)D with cognitive function in epilepsy patients: A cross-sectional study

Xin Du, Bingbing Wang, Li Shao

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109935 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Xin Du und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou City, China. Hauptthemen laut MEDLINE: Epilepsy, Vitamin D. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To analyze the correlation between the level of 25(OH)D in peripheral blood and cognitive function in patients with epilepsy, and to find the biomarkers of epilepsy complicated with cognitive dysfunction. METHODS: 68 patients with epilepsy and 30 healthy subjects were included in this study. The 25(OH)D level in peripheral blood of all subjects was detected and the score of the Montreal Cognitive Assessment Scale was performed. The patients with epilepsy were divided into a cognitively normal group (36 cases) and a cognitively impaired group (32 cases) according to the scale score. The inter-group scale score and 25(OH)D level were compared, and the correlation was analyzed. RESULTS: The levels of 25(OH)D and MOCA in epileptic group were significantly lower than those in healthy control group. The 25(OH)D and MOCA of the cognitively impaired group were significantly lower than those of the cognitively normal group. Logistic regression analysis indicated that serum 25(OH)D level was an independent risk factor for epilepsy combined with cognitive impairment (OR = 0.704, P = 0.014). The area under ROC curve of serum 25(OH)D for diagnosis of epilepsy combined with cognitive impairment was 0.924 (95 %CI 0.866,0.981), the critical value was 34.50 nmol/L, the sensitivity was 0.778, and the specificity was 0.906. CONCLUSION: Decreased levels of vitamin D are associated with cognitive impairment associated with epilepsy, and it may be a biomarker for early screening of cognitive impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyVitamin DHumansFemaleMaleAdultCross-Sectional StudiesMiddle AgedYoung AdultMental Status and Dementia TestsCognitive DysfunctionCognitionNeuropsychological TestsROC Curve

Stichwörter der Autor:innen

25(OH)DCognitive functionEpilepsy

Substanzen

Vitamin D25-hydroxyvitamin D

Autor:innen und Institutionen

  • Department of Neurology, The Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou City, China.
  • Department of Neurology, Suining County People's Hospital, Xuzhou City, China.
  • Department of Neurology, The Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou City, China. Electronic address: 862647275@qq.com.

Zitieren

APA

Du, X., Wang, B., & Shao, L. (2024). Correlation analysis of 25(OH)D with cognitive function in epilepsy patients: A cross-sectional study. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109935

Vancouver

Du X, Wang B, Shao L. Correlation analysis of 25(OH)D with cognitive function in epilepsy patients: A cross-sectional study. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109935

BibTeX
@article{Du2024,
  author = {Du, Xin and Wang, Bingbing and Shao, Li},
  title = {Correlation analysis of 25(OH)D with cognitive function in epilepsy patients: A cross-sectional study},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109935}
}
Kostenlos starten →